Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs

Scholarly Works

• Akturk, O.; Yilmaz, B. Cellular interactions and design principles of glyco-gold nanoparticles for drug delivery applications. Gold Nanoparticles for Drug Delivery; Elsevier, 2024; pp 85–119. doi:10.1016/b978-0-443-19061-2.00012-2
• Mehrotra, S.; Salwa; BG, P. K.; Bhaskaran, N. A.; Srinivas Reddy, J.; Kumar, L. Nose-to-Brain delivery of antiretroviral drug loaded lipidic nanocarriers to purge HIV reservoirs in CNS: A safer approach. Journal of Drug Delivery Science and Technology 2023, 87, 104833. doi:10.1016/j.jddst.2023.104833
• Zakharova, O. V.; Vasyukova, I. A.; Gusev, A. A. Metal-Based Nanoparticles for the Diagnostics, Therapy, and Prevention of Viral Infections. Nanobiotechnology Reports 2023, 18, 165–188. doi:10.1134/s2635167623700027
• Rana, A.; Pathak, S.; Lim, D.-K.; Kim, S.-K.; Srivastava, R.; Sharma, S. N.; Verma, R. Recent Advancements in Plant- and Microbe-Mediated Synthesis of Metal and Metal Oxide Nanomaterials and Their Emerging Antimicrobial Applications. ACS Applied Nano Materials 2023, 6, 8106–8134. doi:10.1021/acsanm.3c01351
• Asl, F. D.; Mousazadeh, M.; Taji, S.; Bahmani, A.; Khashayar, P.; Azimzadeh, M.; Mostafavi, E. Nano drug-delivery systems for management of AIDS: liposomes, dendrimers, gold and silver nanoparticles. Nanomedicine (London, England) 2023, 18, 279–302. doi:10.2217/nnm-2022-0248
• Shabatina, T. I.; Vernaya, O. I.; Shimanovskiy, N. L.; Melnikov, M. Y. Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents. Pharmaceutics 2023, 15, 1181. doi:10.3390/pharmaceutics15041181
• Mbatha, L. S.; Akinyelu, J.; Chukwuma, C. I.; Mokoena, M. P.; Kudanga, T. Current Trends and Prospects for Application of Green Synthesized Metal Nanoparticles in Cancer and COVID-19 Therapies. Viruses 2023, 15, 741. doi:10.3390/v15030741
• Azab, W. Antiviral potential of nanomaterials: The fight against viruses. Antimicrobial Activity of Nanoparticles; Elsevier, 2023; pp 101–132. doi:10.1016/b978-0-12-821637-8.00005-5
• Sultan, G.; Madar, I. H.; Zahra, S. M.; Safdar, M.; Alahmad, U. F.; Begum, M.; Chelliah, R.; Oh, D.-H. Management of infectious disease and biotoxin elimination using nanomaterials. Advances in Smart Nanomaterials and their Applications; Elsevier, 2023; pp 149–174. doi:10.1016/b978-0-323-99546-7.00016-1
• Behzad, F.; Kalyani, F. N.; Samadi, A.; Adabi, M. A promising treatment for HIV-1 using biosynthesis of metal nanoparticles. Journal of Industrial and Engineering Chemistry 2022, 115, 20–25. doi:10.1016/j.jiec.2022.07.052
• Yañez-Aulestia, A.; Gupta, N. K.; Hernández, M.; Osorio-Toribio, G.; Sánchez-González, E.; Guzmán-Vargas, A.; Rivera, J. L.; Ibarra, I. A.; Lima, E. Gold nanoparticles: current and upcoming biomedical applications in sensing, drug, and gene delivery. Chemical communications (Cambridge, England) 2022, 58, 10886–10895. doi:10.1039/d2cc04826d
• Ncobeni, N.; de la Torre, B. G.; Albericio, F.; Kruger, H. G.; Parboosing, R. Active targeting of CD4+T lymphocytes by PEI-capped, peptide-functionalized gold nanoparticles. Nanotechnology 2022, 33, 405101. doi:10.1088/1361-6528/ac7885
• Jadhav, S.; Yenorkar, N.; Bondre, R.; Karemore, M.; Bali, N. Nanomedicines encountering HIV dementia: A guiding star for neurotherapeutics. Journal of Drug Delivery Science and Technology 2022, 71, 103315. doi:10.1016/j.jddst.2022.103315
• Soundararajan, D.; Ramana, L. N.; Shankaran, P.; Krishnan, U. M. Nanoparticle-based strategies to target HIV-infected cells. Colloids and surfaces. B, Biointerfaces 2022, 213, 112405. doi:10.1016/j.colsurfb.2022.112405
• Kenguva, G.; Rout, S. R.; Bandaru, R.; Dandela, R.; Sahebkar, A.; Kesharwani, P. Combination drug delivery approaches for viral infections. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases; Elsevier, 2022; pp 129–147. doi:10.1016/b978-0-323-85873-1.00007-1
• Chaitanya, T. S.; Patil, S. N.; Ghosh, S.; Pal, J. K.; Yuba, E.; Gupta, R. K. Cross-presentation-based nanovaccine for cancer immunotherapy. Nanotherapeutics in Cancer Vaccination and Challenges; Elsevier, 2022; pp 349–396. doi:10.1016/b978-0-12-823686-4.00015-x
• Ahmad, M. Z.; Mohammed, A. A.; Pathak, K.; Gogoi, U.; Saikia, R.; Ahmad, J. Metallic nanomaterials for the diagnosis and treatment of infectious diseases. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases; Elsevier, 2022; pp 289–317. doi:10.1016/b978-0-323-91201-3.00009-8
• Jannat, K.; Paul, A. K.; Bondhon, T. A.; Hasan, A.; Nawaz, M.; Jahan, R.; Mahboob, T.; Nissapatorn, V.; Wilairatana, P.; de Lourdes Pereira, M.; Rahmatullah, M. Nanotechnology Applications of Flavonoids for Viral Diseases. Pharmaceutics 2021, 13, 1895. doi:10.3390/pharmaceutics13111895
• Das, R.; Mukhopadhyay, B. A brief insight to the role of glyconanotechnology in modern day diagnostics and therapeutics. Carbohydrate research 2021, 507, 108394. doi:10.1016/j.carres.2021.108394
• Hasanzadeh, A.; Alamdaran, M.; Ahmadi, S.; Nourizadeh, H.; Bagherzadeh, M. A.; Jahromi, M. A. M.; Simon, P.; Karimi; Hamblin, M. R. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. Journal of controlled release : official journal of the Controlled Release Society 2021, 336, 354–374. doi:10.1016/j.jconrel.2021.06.036

Explore citations to this article at